HomeAbout UsPortfolioNewsContact Us

  • POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES

    Domain expertise, global resource, long-term capital

  • PORTFOLIO NEWS

    IMPACT Announces Completion of RMB 250 million Sr. D++ Financing
    November 15, 2024
    SHANGHAI, November 15th, 2024 - IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company...
    GSK enters agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline
    October 29, 2024
    CMG1A46 is an investigational T cell-engager with potential to deeply deplete uncontrolled B...
    Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of next-generation CDK inhibitors for the Treatment of Breast Cancer
    September 30, 2024
    Cambridge, Massachusetts, September 30, 2024 - Regor Pharmaceuticals (USA) ("Regor") has entered...
    More Posts
    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More